中晚期肝癌的治疗探讨

TREATMENT FOR ADVANCED PRIMARY HEPATOCELLULAR CARCINOMA

本文总结61例中晚期肝癌的治疗。插管组21例，局切组32例，局切插管组8例。结果：插管组近期有效率为66．7％。AFP下降（或转阴）率分别为：33．3％、39．29％、71．41％。三组中位生存期分别为：9．6、11．2、13．4个月。各组3个月、6个月、1年、2年生存率分别为：85．7％、87．5％、100％；66．7％、71．9％、87．5％；35％、40．6％、57．1％；0％、10．3％、20％。提示：局部切除插管组优于局部切除组及插管组，手术治疗组明显优于非手术插管组（P<O．05）。

Sixty-one cases of advanced primary hepatocellular carcinoma were studied,of which 21 cases was in the transvascular group, 32 cases in the local resection group and 8 cases in the local resection and transvascular group. The recent effective rate of transvascular group was 66. 7 %. In the three subgroups,the medium survival duration were 9. 6.11. 2. 13. 4 months respectively. The rate of decline or return to normal of AFP were 33. 3% 39. 29. 71. 41% . the 3 - month. 6 - Month. 1 -year, 2 - Year survival rates of these subgroups of patients were 85. 7 % .87. 5. 100%; 66. 7% .71. 9 94 .87. 5 % 1 35 % .40. 6%,57. 1 % ic%' 10. 3 %.20%,respectively. It is suggested that the local respition and transvascular group is more effective than the local resection group or the transvascular group. The surgical removal of tumor was more effective than the,anresectable cases(PM<O. 05)